« Back to Medicines list

Metatone Tonic

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 22/03/21

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 22/3/2021

Click on this link to Download PDF directly

Chefaro Ireland DAC

Chefaro Ireland Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name Abidec Drops Active Ingredients Ascorbic acid, nicotinamide (B3), Pyridoxine Hydrochloride (Vitamin B6), Riboflavine (Vitamin B2), Thiamine Hydrochloride (Vitamin B1), Vitamin A (Palmitate), Vitamin D2 (ergocalciferol)
Medicine Name Beconase Hayfever Active Ingredients Beclometasone Dipropionate Monohydrate
Medicine Name Buttercup Bronchostop Berry Flavour Cough Pastilles Active Ingredients Thyme herb extract
Medicine Name Buttercup Bronchostop Cough Syrup Active Ingredients Marshmallow root extract, Thyme herb extract
Medicine Name Cetirizine dihydrochloride 10mg Film-coated Tablets Active Ingredients Cetirizine Dihydrochloride
Medicine Name Lyclear Creme Rinse Active Ingredients Permethrin
Medicine Name Metatone Tonic Active Ingredients Calcium glycerophosphate, Manganese glycerophosphate, Potassium glycerophosphate, Sodium glycerophosphate, Thiamine Hydrochloride (Vitamin B1)
Medicine Name Milk of Magnesia Active Ingredients Magnesium Hydroxide
Medicine Name NiQuitin 14 mg/24hrs transdermal patches Active Ingredients Nicotine
Medicine Name NiQuitin 21mg/24hrs transdermal patches Active Ingredients Nicotine
Medicine Name NiQuitin 7mg/24hrs transdermal patches Active Ingredients Nicotine
Medicine Name NiQuitin CLEAR 14 mg/24 hours transdermal patch Active Ingredients Nicotine
Medicine Name NiQuitin CLEAR 21 mg/24 hours transdermal patch Active Ingredients Nicotine
Medicine Name NiQuitin CLEAR 7 mg/24 hours transdermal patch Active Ingredients Nicotine
Medicine Name NiQuitin Mini 1.5mg Mint Lozenges Active Ingredients Nicotine resinate
Medicine Name NiQuitin Mini 4mg Mint Lozenges Active Ingredients Nicotine resinate
Medicine Name Nytol One-A-Night 50 mg Tablets Active Ingredients Diphenhydramine Hydrochloride
Medicine Name Paracetamol 500 mg Film-Coated Tablets (GSL) Active Ingredients Paracetamol
Medicine Name Paracetamol 500 mg Film-Coated Tablets (p) Active Ingredients Paracetamol
Medicine Name Solpa-Extra Soluble Tablets Active Ingredients Caffeine, Paracetamol
Medicine Name Solpa-Plus tablets Active Ingredients Codeine Phosphate Hemihydrate, Paracetamol
Medicine Name solpa-plus with caffeine soluble tablets Active Ingredients Caffeine, Codeine Phosphate Hemihydrate, Paracetamol
Medicine Name Solpa-Sinus Film-coated Tablets Active Ingredients Paracetamol, Pseudoephedrine Hydrochloride
Medicine Name Solpadeine Capsules Active Ingredients Caffeine, Codeine Phosphate Hemihydrate, Paracetamol
Medicine Name Solpadeine Soluble Tablets Active Ingredients Caffeine, Codeine Phosphate Hemihydrate, Paracetamol
1 - 0 of 33 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 22 March 2021 PIL

Reasons for updating

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 22 March 2021 SPC

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Updated on 8 June 2020 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Updated on 8 June 2020 SPC

Reasons for updating

  • Change to MA holder contact details

Legal category: Supply through pharmacy only

Updated on 25 April 2017 SPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

 7 MARKETING AUTHORISATION HOLDER

Chefaro Ireland DAC, Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland.

Updated on 25 April 2017 SPC

Reasons for updating

  • New SPC for new product

Legal category: Supply through pharmacy only

Updated on 21 April 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 21 April 2017 PIL

Reasons for updating

  • Change to section 6 - date of revision
  • Change to MA holder contact details

Updated on 15 June 2015 SPC

Reasons for updating

  • Correction of spelling/typing errors

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

section 4.8 - typographical correction of symbols in relation to frequency classification

Updated on 12 June 2015 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision

Updated on 12 June 2015 SPC

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

4.4 (Special Warnings) - addition of sodium warning for patients on a controlled sodium diet.
4.8 (Undesirable Effects) - addition of statement that Metatone contains actives with well established safety profile and has limited adverse events when taken correctly; addition of  adverse events frequency classification statement, and addition of the following adverse events Hypersensitivity, Abdominal discomfort, nausea, vomiting, diarrhoea, constipation, Allergic skins reactions and Malaise (all frequency not known); addition of adverse event report statement for Ireland.
10 (Date of Revision of the Text) - changed to May 2015.

Updated on 29 August 2013 SPC

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 6.3 (shelf life): the shelf life of the 300ml presentation is extended from 24 months to 36 months (aligning it with the 500ml presentation)

Updated on 23 August 2013 SPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • SPC retired pending re-submission

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 7 (Marketing Authorisation Holder), the address of the MAH has been updated.

Updated on 20 August 2013 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 30 August 2012 SPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

None provided